Register for OBR daily


To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

CBMG $33.00 6.8299 +26.10%
Kite $23.53 1.5100 +6.86%
EXEL $4.40 0.2100 +5.01%
PCYC $108.50 3.6800 +3.51%
CLSN $3.47 0.0800 +2.36%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

CERU $4.28 -0.5200 -10.83%
TGTX $7.91 -0.5300 -6.28%
INO $11.90 -0.7300 -5.78%
ECYT $5.96 -0.3400 -5.40%
GALT $14.54 -0.7800 -5.09%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 888 | 889 | 890 | 891 | 892 | 893 | 894 | 895 | 896 | 897 | Next > | Last >>

Coordinating Office Established to Advance MENA/NCCN Collaboration

(NCCN) Dec 14, 2010 - In an effort to advance oncology care available to patients in the Middle East and North Africa (MENA) region, the National Comprehensive Cancer Network (NCCN) announces the MENA Coordinating Office for NCCN Collaboration.
read press release 

Global Health Watch: India Delays Placing Graphic Pictorial Warnings on Cigarette Packs for a Year

(Los Angeles Times) Dec 13, 2010 - Under threat from cigarette manufacturers, the Indian government has deferred the use of new, pictorial warnings on cigarette packs by a year. The new warnings, part of India's anti-smoking effort, were to be implemented on Dec. 1 after earlier delays in March.
read article (free registration required) 

Pfizer Meets Doctors Online With Free Drug Samples

(Morningstar/DowJones Newswires) Dec 14, 2010 - Pfizer Inc. has become the latest drug company to offer doctors the option of using the Internet to order free samples of its drugs, a trend illustrating the diminished role of sales representatives, whose ranks continue to decrease.
read article 

Drug Companies' Reports Aren't Always Accurate

(The Star Tribune) Dec 12, 2010 - A new federal plan will require drug and medical device companies to report all payments to U.S. physicians in 2013. The danger? As Minnesota found, some information may be incorrect.
read article 

Narcotic Painkillers May Pose Danger to Elderly Patients, Study Says

(New York Times) Dec 13, 2010 - A review cited a higher risk of bone fracture, heart attack and death with use of narcotic-based drugs.
read article (free registration required) 

Vivus Submits Qnexa Response To FDA; Meeting Set For January

(NASDAQ/Dow Jones Newswires) Dec 14, 2010 - Vivus Inc. said it has responded to the U.S. Food and Drug Administration's concerns about obesity drug Qnexa and has set a meeting for late January to discuss the company's latest effort to win its approval.
read article 

Pfizer Names George Lorch Chairman, Boosts Dividend

(USA Today) Dec 13, 2010 - Drug developer Pfizer says it named George A. Lorch as its new chairman of the board of directors.
read article 

Sanofi Names Zerhouni New R&D Head

(Wall Street Journal) Dec 14, 2010 - Sanofi-Aventis S.A. named a new head of research and development Tuesday, as the French drugs giant pushes ahead with plans to redesign its product portfolio to offset revenue that will be lost as patents expire.
read article (paid subscription required) 

XGEVA(TM) (Denosumab) Significantly Improved Bone Metastasis-Free Survival in Men With Prostate Cancer

(Amgen) Dec 13, 2010 - Pivotal Phase 3 '147 study meets primary endpoint; first bone-targeted therapy to delay the onset of bone metastases in patients with prostate cancer.
read press release 

Lilly Suspends Phase III Trial in Metastatic Melanoma

(Eli Lilly) Dec 13, 2010 - Eli Lilly and Company announced today that it has suspended its global Phase III study evaluating tasisulam, an investigational, small-molecule anti-cancer compound, as a second-line treatment for those with unresectable or metastatic melanoma.
read press release 

Roche's Avastin Didn't Beat Chemotherapy as Early Breast Cancer Treatment

(Bloomberg) Dec 10, 2010 - Roche Holding AG’s Avastin failed to eradicate tumor cells better than standard chemotherapy in women with early stage breast cancer, a finding that could limit the efforts to expand use of the oncology drug.
read article 

Immunogen-Roche Breast-Cancer Drug Has Positive Response In Early Trial

(SmartMoney/Dow Jones Newswires) Dec 10, 2010 - Immunogen Inc. said Friday a breast-cancer treatment it is developing with Roche Holding AG improved the condition of more than half the patients of an early-stage study when tested with another Roche drug.
read article 

Popular New Breast Cancer Treatment Lacks Data

(Reuters) Dec 10, 2010 - A new radiation treatment for breast cancer is becoming increasingly popular despite lack of good evidence, at least among well-insured Medicare patients, U.S. researchers say.
read article 

Higher Co-Payments Increase Chance of Early Discontinuation, Inadequate Use of Breast Cancer Therapy

(AACR) Dec 11, 2010 - A higher prescription co-payment, especially among older women, is associated with both early discontinuation and incomplete use of adjuvant aromatase inhibitor therapy, a lifesaving therapy for women with hormone sensitive early-stage breast cancer.
read press release 

More Node Negative Patients Surviving Breast Cancer: Findings Reported at 2010 San Antonio Breast Cancer Symposium

(US Oncology) Dec 11, 2010 - Stephen Jones, M.D., medical director for US Oncology Research participated in the TEAM (Tamoxifen Exemestane Adjuvant Multinational) study that included nearly 10,000 patients over a five-year period in node negative breast cancer; the study found that the odds of dying of other causes were greater than the risk of death from breast cancer.
read press release 

Cancer Patients May Reduce Fast Growing Breast Cancer Recurrences: Findings Reported at 2010 San Antonio Breast Cancer Symposium

(US Oncology) Dec 10, 2010 - Joyce O’Shaughnessy, M.D. presented study findings today at the 33rd Annual San Antonio Breast Cancer Symposium (SABCS) suggesting that Xeloda may reduce recurrence of faster growing breast cancers.
read press release 

Pregnant Cancer Patients Shouldn’t Delay Treatment, Speed Birth

(Bloomberg Businessweek) Dec 11, 2010 - Pregnant women who are diagnosed with breast cancer shouldn’t delay treatment or hasten delivery to avoid exposing the baby to chemotherapy, doctors said.
read article 

Novel Imaging Technique May Reduce Lymphedema in Breast Cancer Patients

(Mayo Clinic) Dec 11, 2010 - With guidance from a specialized scan, radiation oncologists at Mayo Clinic were able to reduce by 55 percent the number of lymph nodes critical for removing fluid from the arm that received damaging radiation doses.
read press release 

Depression Drug May Relieve Pain From Breast Cancer Treatment, Study Finds

(UMHS) Dec 13, 2010 - A drug commonly used to treat depression and anxiety disorder was effective at reducing joint and muscle pain associated with a breast cancer treatment, according to a study from the University of Michigan Comprehensive Cancer Center.
read press release 

Expert Analysis of HER2 Breast Cancer Tests Reveals Issues With Reliability, Mayo Clinic Researchers Say

(Mayo Clinic) Dec 11, 2010 - Results for testing breast tumors for HER2 proteins and genes is most often straightforward when one piece of tumor (a single tumor block) is analyzed. However, tumors can be diverse, and researchers at Mayo Clinic found that HER2 results can vary in up to 10 percent of patients when several tumor blocks are analyzed.
read press release 

NKTR-102 Demonstrates Significant Efficacy as Single-Agent in Second- or Third-Line Treatment in Metastatic Breast Cancer Patients

(MSN Money) Dec 12, 2010 - Nektar Therapeutics today announced positive results from a Phase 2 clinical study evaluating single-agent NKTR-102 in patients with metastatic breast cancer during the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS).
read article 

Genomic Health Announces Multiple Studies Highlighting Important Role of Oncotype DX® in Treating the Underlying Biology of Early-Stage Breast Cancer

(Genomic Health) Dec 13, 2010 - Genomic Health, Inc. today announced results from seven new studies focusing on its multigene Oncotype DX® breast cancer test, which has helped guide treatment decisions in more than 175,000 breast cancer patients worldwide.
read press release 

bioTheranostics' Breast Cancer Index(SM) Predicts Risk for Late Recurrence in Early Stage ER-Positive Breast Cancer Patients

(Yahoo! Finance) Dec 10, 2010 - bioTheranostics, a bioMerieux company that develops innovative oncology diagnostic tests to support targeted disease management, announced today new findings from a clinical study evaluating the company's Breast Cancer Index (BCI) molecular oncology test.
read article 

Simple Test for Breast Cancer Patients

(The Times of India) Dec 11, 2010 – A simple test that measures a breast cancer patient's ability to feel two metal points pressed against her fingertips may help evaluate the risk for developing carpal tunnel syndrome (CTS), a new study by Johns Hopkins Kimmel Cancer Center researchers has shown.
read article 

Study Explains Why Omega-3 Fatty Acids Prevent Breast Cancer

(Tehran Times) Dec 13, 2010 - Omega-3 fatty acids have been found to provide a preventative effect against breast cancer. A new study shows omega-3 fatty acids render the preventative effect by suppressing the NF-kB transcription activity, nuclear localization and overall function.
read article